![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Pfizer-BioNTech Vaccine to be Partly Produced in South Africa
Pfizer-BioNTech Vaccine to be Partly Produced in South Africa
Pfizer and BioNTech have teamed up with a South African drugmaker that will help produce their COVID-19 vaccine for distribution throughout Africa.
Cape Town-based Biovac will manufacture finished vaccine doses beginning in 2022, with annual production expected to reach more than 100 million doses, the companies said.
Pfizer has had a working relationship since 2015 with Biovac, which manufactures and distributes Pfizer’s Prevenar 13 pneumococcal vaccine.
Upcoming Events
-
18Jul
-
21Oct